Key Takeaways
- • Apollo Global Management and Neuberger Berman co-led a $780 million secondary transaction for Abry Partners' Centauri Health Solutions, demonstrating continued institutional appetite for GP-led secondary deals in healthcare technology.
- • Neuberger Berman has positioned itself as a major player in the GP-led secondary market, having raised over $4 billion for its NB Strategic Capital Fund II (exceeding its $2.5 billion target) and securing commitments across multiple continuation fund structures.
- • The Centauri deal leverages the secondary market's growth trajectory, where investors seek liquidity opportunities and portfolio optimization in mature private equity positions, particularly within high-growth healthcare sectors.
- • Apollo's involvement underscores the firm's commitment to secondary solutions, complementing its $5.4 billion S3 Equity and Hybrid Solutions fund raised to facilitate early exits from private funds amid constrained dealmaking conditions.
- • The transaction reflects broader market dynamics in which GP-led secondaries have become critical mechanisms for extending fund lifecycles and generating returns for limited partners facing extended holding periods.
Summary
Apollo Global Management and Neuberger Berman co-led a $780 million secondary transaction for Abry Partners' Centauri Health Solutions, according to reporting on the deal dated June 15, 2026. The transaction exemplifies the scaling of GP-led secondary mechanisms as institutional investors navigate extended private equity holding periods and seek structured liquidity solutions.
Neuberger Berman has emerged as a dominant force in the GP-led secondary market. The firm closed its NB Strategic Capital Fund II at just over $4 billion in total capital commitments—exceeding its $2.5 billion target by 60 percent—positioning it among the market's largest dedicated secondary vehicles. This fund, which supplements the firm's broader secondaries practice, demonstrates strong institutional demand for vehicles that facilitate continuation funds, portfolio restructuring, and extended fund lifecycles across multiple investment verticals.
Apollo's role as co-lead of the Centauri secondary reflects the firm's broader strategic pivot toward secondary solutions. Apollo previously raised approximately $5.4 billion for its S3 Equity and Hybrid Solutions fund, which enables investors to exit private equity positions ahead of traditional fund maturity schedules. This fundraising activity occurred amid a sluggish dealmaking environment, indicating that secondary markets have become a critical valve for managing liquidity pressures in the private markets ecosystem.
The Centauri transaction specifically targets Abry Partners' healthcare technology portfolio company, reflecting sustained institutional capital flow into healthcare sector secondaries. Abry Partners has been active in the secondary market, having orchestrated a $1.6 billion GP-led credit transaction through Coller Capital that created a continuation vehicle for its Advanced Securities portfolio. The Centauri deal aligns with this pattern, in which established sponsors deploy secondary mechanisms to extend platform economics and provide limited partners with refined exit optionality.
The $780 million capital commitment underscores the maturation of secondary deal sizes and the competitive dynamics among tier-one managers—Apollo, Neuberger Berman, and their co-investors—competing for large continuation opportunities in core healthcare technology assets. This activity reflects sustained institutional confidence in secondary structures as a permanent feature of the modern private markets infrastructure.
Neuberger Berman has emerged as a dominant force in the GP-led secondary market. The firm closed its NB Strategic Capital Fund II at just over $4 billion in total capital commitments—exceeding its $2.5 billion target by 60 percent—positioning it among the market's largest dedicated secondary vehicles. This fund, which supplements the firm's broader secondaries practice, demonstrates strong institutional demand for vehicles that facilitate continuation funds, portfolio restructuring, and extended fund lifecycles across multiple investment verticals.
Apollo's role as co-lead of the Centauri secondary reflects the firm's broader strategic pivot toward secondary solutions. Apollo previously raised approximately $5.4 billion for its S3 Equity and Hybrid Solutions fund, which enables investors to exit private equity positions ahead of traditional fund maturity schedules. This fundraising activity occurred amid a sluggish dealmaking environment, indicating that secondary markets have become a critical valve for managing liquidity pressures in the private markets ecosystem.
The Centauri transaction specifically targets Abry Partners' healthcare technology portfolio company, reflecting sustained institutional capital flow into healthcare sector secondaries. Abry Partners has been active in the secondary market, having orchestrated a $1.6 billion GP-led credit transaction through Coller Capital that created a continuation vehicle for its Advanced Securities portfolio. The Centauri deal aligns with this pattern, in which established sponsors deploy secondary mechanisms to extend platform economics and provide limited partners with refined exit optionality.
The $780 million capital commitment underscores the maturation of secondary deal sizes and the competitive dynamics among tier-one managers—Apollo, Neuberger Berman, and their co-investors—competing for large continuation opportunities in core healthcare technology assets. This activity reflects sustained institutional confidence in secondary structures as a permanent feature of the modern private markets infrastructure.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.